Diseases, Conditions, Syndromes

RSV: We finally have a vaccine for this deadly virus

The first vaccine against respiratory syncytial virus (RSV) has been approved by the US Food and Drug Administration. The vaccine, named Arexvy, will be given to people 60 years and older.

Health

Review highlights the health hazards of air pollution in China

Globally, air pollution is a major public health hazard. A key air pollutant linked to health risks is ambient fine particulate matter (PM2.5), which consists of minute particles, sized less than or equal to 2.5 μm, suspended ...

Diseases, Conditions, Syndromes

FDA approves first RSV vaccine

The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 and older.

page 38 from 40